George A Calin Selected Research

MicroRNAs (MicroRNA)

10/2022	Cellular microRNAs correlate with clinical parameters in multiple injury patients.
3/2022	MicroRNAs in Leukemias: A Clinically Annotated Compendium.
3/2022	Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer.
1/2022	RNAi-based therapeutics and tumor targeted delivery in cancer.
1/2022	Classical and noncanonical functions of miRNAs in cancers.
1/2022	Targeting non-coding RNAs to overcome cancer therapy resistance.
1/2021	Noncoding RNA therapeutics - challenges and potential solutions.
1/2021	MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44.
1/2021	Being Small and Intronic: miRNAs That Count!
12/2020	Interrupting Neuron-Tumor Interactions to Overcome Treatment Resistance.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George A Calin Research Topics

Disease

253	Neoplasms (Cancer) 03/2022 - 01/2003
39	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2007
38	Carcinogenesis 01/2022 - 06/2006
26	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2003
24	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 08/2005
18	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 01/2003
14	Leukemia 03/2022 - 01/2005
12	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 09/2007
9	Lung Neoplasms (Lung Cancer) 12/2019 - 08/2005
8	Prostatic Neoplasms (Prostate Cancer) 02/2017 - 08/2008
8	Carcinoma (Carcinomatosis) 12/2015 - 01/2003
7	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 05/2011
7	Hypoxia (Hypoxemia) 01/2020 - 03/2007
6	Disease Progression 05/2022 - 08/2014
6	Triple Negative Breast Neoplasms 03/2022 - 03/2015
6	Sepsis (Septicemia) 01/2022 - 10/2009
5	Colonic Neoplasms (Colon Cancer) 12/2020 - 08/2007
5	Lymphoma (Lymphomas) 10/2020 - 01/2005
5	Adenocarcinoma 08/2016 - 08/2008
4	Infections 10/2022 - 01/2005
4	Inflammation (Inflammations) 10/2022 - 01/2015
4	Stomach Neoplasms (Stomach Cancer) 05/2022 - 02/2010
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021 - 03/2008
4	Urinary Bladder Neoplasms (Bladder Cancer) 02/2021 - 09/2007
4	Microsatellite Instability 12/2020 - 08/2007
4	Hepatocellular Carcinoma (Hepatoma) 11/2018 - 07/2007
4	Chromosome Aberrations (Chromosome Abnormalities) 04/2016 - 03/2008
4	Hematologic Neoplasms (Hematological Malignancy) 01/2015 - 01/2008
4	Inborn Genetic Diseases (Disease, Hereditary) 02/2011 - 09/2007
3	Adenocarcinoma of Lung 01/2022 - 02/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 12/2015
3	Squamous Cell Carcinoma of Head and Neck 01/2020 - 09/2013
3	Brain Neoplasms (Brain Tumor) 05/2019 - 01/2008
3	Glioma (Gliomas) 01/2016 - 07/2013
3	Neuroblastoma 07/2015 - 03/2010
3	Adenoma (Adenomas) 12/2011 - 08/2005
2	Rett Syndrome (Rett's Disorder) 03/2022 - 10/2010
2	Chromosomal Instability (Chromosome Stability) 12/2020 - 09/2013
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2020 - 10/2013
2	Multiple Myeloma 01/2020 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 05/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 05/2010
2	Liver Neoplasms (Liver Cancer) 01/2018 - 05/2016
2	Melanoma (Melanoma, Malignant) 05/2017 - 03/2015
2	Inflammatory Breast Neoplasms 01/2016 - 01/2014
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2015 - 07/2011

Drug/Important Bio-Agent (IBA)

223	MicroRNAs (MicroRNA)IBA 10/2022 - 07/2005
55	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2003
47	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2008
25	Long Noncoding RNAIBA 01/2022 - 01/2011
18	Biological ProductsIBA 03/2022 - 03/2003
17	RNA (Ribonucleic Acid)IBA 10/2022 - 12/2007
16	Messenger RNA (mRNA)IBA 01/2022 - 08/2007
14	Untranslated RNA (Noncoding RNA)IBA 01/2022 - 09/2007
13	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2003
12	Pharmaceutical PreparationsIBA 01/2021 - 09/2008
9	Phosphotransferases (Kinase)IBA 03/2022 - 03/2010
7	Immune Checkpoint InhibitorsIBA 01/2021 - 05/2018
5	Circular RNAIBA 03/2022 - 01/2018
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2009
4	Small Interfering RNA (siRNA)IBA 05/2022 - 11/2013
4	AntagomirsIBA 01/2022 - 01/2015
4	AntigensIBA 04/2020 - 07/2015
4	Estrogens (Estrogen)FDA Link 01/2020 - 08/2005
4	Trastuzumab (Herceptin)FDA Link 01/2018 - 01/2012
4	Epidermal Growth Factor (EGF)IBA 01/2018 - 01/2003
3	NucleotidesIBA 01/2021 - 07/2007
3	Insulin-Like PeptidesIBA 04/2020 - 10/2019
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 09/2013
3	Hormones (Hormone)IBA 12/2019 - 03/2010
3	human ERBB2 proteinIBA 01/2017 - 05/2012
3	Therapeutic UsesIBA 01/2016 - 07/2013
2	CytokinesIBA 10/2022 - 01/2018
2	ChemokinesIBA 10/2022 - 12/2020
2	Peptides (Polypeptides)IBA 11/2021 - 01/2020
2	Nerve Growth Factor (NGF)IBA 01/2021 - 12/2020
2	AndrogensIBA 01/2021 - 08/2008
2	CateninsIBA 01/2021 - 12/2011
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021 - 01/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2020 - 01/2018
2	Cadherins (E-Cadherin)IBA 10/2020 - 11/2004
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2020 - 01/2017
2	Histones (Histone)IBA 01/2020 - 10/2013
2	Glutamine (L-Glutamine)FDA Link 01/2020 - 02/2016
2	Antisense OligonucleotidesIBA 05/2019 - 01/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019 - 01/2017
2	NF-kappa B (NF-kB)IBA 10/2018 - 01/2015
2	ElementsIBA 07/2018 - 11/2004
2	Liposomes (Liposome)IBA 05/2017 - 11/2013
2	Tumor Biomarkers (Tumor Markers)IBA 05/2017 - 01/2003
2	LigandsIBA 01/2017 - 07/2015
2	Glucose (Dextrose)FDA LinkGeneric 05/2016 - 02/2016
2	Cisplatin (Platino)FDA LinkGeneric 03/2016 - 07/2015

Therapy/Procedure

71	Therapeutics 05/2022 - 08/2005
17	Drug Therapy (Chemotherapy) 01/2022 - 05/2012
5	Radiotherapy 02/2022 - 12/2015
4	Immunotherapy 01/2022 - 01/2019
3	Precision Medicine 01/2022 - 05/2012
2	RNAi Therapeutics 01/2022 - 06/2014
2	Intravenous Administration 01/2018 - 01/2016